Miscellaneous and General

47 Index.

The expressions listed in the left-hand column below are respectively defined or (as the case may be) are to be interpreted in accordance with the provisions of this Act listed in the right-hand column in relation to those expressions.

Activities governed by this Act

Section 4(5)

F1Appeals committee

F1Section 20A(2)

Authority

Section 2(1)

F2Basic partner treatment services

Section 2(1)

Carry, in relation to a child

Section 2(3)

F3. . .

F3. . .

Directions

Section 2(1)

F4Distribution, in relation to gametes or embryos intended for human application

Section 2(1)

Embryo F5(except in section 4A or in the term “human admixed embryo”)

Section 1

F6First Directive

Section 1A

F7Fourth Directive

Section 1A

Gametes, eggs or sperm F8(except in section 4A)

Section 1

F1Human admixed embryo

F1Section 4A(6)

F9Human application

Section 2(1)

F7Importing licensee

Section 2B(2

Keeping, in relation to embryos or gametes

Section 2(2)

Licence

Section 2(1)

F10. . .

F10. . .

F10. . .

F10. . .

F11Non-medical fertility services

Section 2(1)

F1Nuclear DNA (in relation to an embryo)

F1Section 2(1)

F12Partner-donated sperm

Section 1(5)

Person responsible

Section 17(1)

Person to whom a licence applies

Section 17(2)

F13Person to whom a third party agreement applies

Section 2A(3)

F14Processing, in relation to gametes or embryos intended for human application

Section 2(1)

F15Procurement, in relation to gametes or embryos intended for human application

Section 2(1)

F7Qualifying gametes or embryos

Section 2B(3)

F16Relevant third party premises, in relation to a licence

Section 2A(2)

F17Second Directive

Section 1A

F18Serious adverse event

Section 2(1)

F19Serious adverse reaction

Section 2(1)

F20. . .

F20. . .

Store, and similar expressions, in relation to embryosF21, human admixed embryos or gametes

F22Section 2(1)

F7Third country

Section 2B(4)

F7Third country premises

Section 2B(5)

F7Third country supplier

Section 2B(6)

F23Third Directive

Section 1A

F24Third party

Section 2A(2)

F25Third party agreement

Section 2A(1)

F26Tissue establishment

Section 2(1)

F27Traceability

Section 2(1)

Treatment services

Section 2(1)